EPXGF yields 13333.33% · PFE yields 6.13%● Live data
📍 EPXGF pulled ahead of the other in Year 1
Combined, EPXGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EPXGF + PFE for your $10,000?
EP&T Global Limited provides building energy management solutions to reduce energy and water wastage, and enhance energy efficiency within commercial real estate in Australia, the United Kingdom, Hong Kong, and the Middle East. Its EDGE platform collects, processes, analyses, visualizes, and interprets sets of data for the environmental performance of buildings. The company's solutions cover energy and water analytics, sustainability reporting, building intelligence, demand management, tenant expenditures identifying, and health and wellbeing. Its EDGE analytics platform collects data from various processed and sources, such as BMS data, weather, sensors, occupancy, meters, and demand management. The company's services comprise customized reporting, alerts/faults triage, performance reviews, curated action items, power factor correction, engineers on call, and building audits. It serves commercial office, retail, hospitals, schools, hotels, clubs, and industrial sectors. The company was founded in 1993 and is headquartered in Sydney, Australia.
Full EPXGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.